Alignment Healthcare Earnings Call Highlights Profitable Growth

Alignment Healthcare, Inc. ((ALHC)) has held its Q4 earnings call. Read on for the main highlights of the call.

Alignment Healthcare’s latest earnings call struck an upbeat tone, emphasizing that strong growth and improving profitability are outweighing regulatory and mix-related headwinds. Management highlighted robust membership and revenue gains, expanding margins, positive free cash flow and best‑in‑class quality scores, while framing policy uncertainty and higher first‑year medical costs for complex members as manageable.

Surging Membership and Top-Line Growth

Alignment reported Q4 health plan membership of about 236,300, up roughly 25% year over year, with full‑year membership also rising 25%. Revenue scaled even faster, reaching $1.0 billion in Q4, a 44% jump, and $3.9 billion for the full year, up 46%, underscoring strong demand for its Medicare Advantage offerings.

Profitability Breakthrough and Margin Expansion

The company turned a corner on profitability, delivering full‑year adjusted EBITDA of $110 million versus roughly breakeven a year earlier, implying a 2.8% margin and about 270 basis points of expansion. Q4 adjusted EBITDA came in at $11 million, handily beating guidance that had called for a potential loss, signaling better cost control and pricing discipline.

Better Medical Benefit Ratio and Gross Profit

Full‑year adjusted gross profit rose to $495 million, with a consolidated medical benefit ratio of 87.5%, an improvement of 130 basis points year over year. In Q4, adjusted gross profit reached $125 million and MBR stood at 87.7%, indicating continued progress in managing medical costs while supporting growth.

Operating Leverage and SG&A Efficiency

Adjusted SG&A expenses grew 28% to $385 million, but Alignment extracted operating leverage as revenue outpaced overhead. SG&A as a share of revenue fell from 11.1% to 9.7%, a roughly 140 basis point improvement, showing that the platform can scale membership without proportionate increases in corporate spending.

Solid Cash Generation and a Stronger Balance Sheet

The business generated positive free cash flow and exited the year with $604 million in cash and investments, giving it ample liquidity to fund growth. Management also closed a $200 million revolving credit facility, which it does not expect to draw, marking another step in maturing the capital structure and boosting financial flexibility.

Strong AEP Results and Early 2026 Momentum

January 2026 membership climbed to about 275,300, representing 31% year‑over‑year growth and broad‑based gains across geographies. California grew 23%, while membership in counties outside the state jumped more than 80%, aided by roughly 20% lower voluntary disenrollment and a sales mix where around 80% of gross adds came from plan switchers.

Replicable Quality and Star Ratings Strength

Alignment underscored that 100% of its members are in plans rated 4 stars or higher, reinforcing its quality positioning in Medicare Advantage. The company now boasts a three‑year 5‑star streak in North Carolina, two 5‑star plans in Nevada, plus highly rated offerings in Texas and Arizona, proving its clinical model travels beyond its California home base.

Technology and Care Model as Competitive Edge

Management spotlighted its AIVA/AVA data platform and Care Anywhere clinical model as key tools for visibility, cost control and scalability. Midyear deployments of new AI use cases and workflow enhancements are expected to further streamline operations, enabling more efficient care management as membership grows.

Brand Recognition and Market Credibility

Alignment’s inclusion on Fortune’s World’s Most Admired Companies list was presented as external validation of its senior‑care focus and culture. This recognition may help the company attract talent, deepen provider partnerships and strengthen its positioning with brokers and consumers in an increasingly competitive marketplace.

Regulatory and Rate Overhangs, Including V28

The call acknowledged industry‑wide concern after CMS signaled a near‑flat net rate environment in its advanced notice, around 0.9%. Alignment also flagged the final phase‑in of the V28 risk model and potential rebasing as headwinds that could pressure medical margins and pricing, even as it works to offset these via operations.

New Member Mix and Higher First-Year MBR

Management explained that 2026 projections assume a heavier mix of low‑income subsidy, dual‑eligible and chronic special needs members, which are core to its strategy but costlier in year one. The company expects this mix to push the first‑year MBR higher, even as underlying capabilities and scale continue to support long‑term margin improvement.

Policy Risk Around Chart Reviews and Integrity Rules

Potential changes in CMS rules, including limits on certain chart reviews and other program‑integrity steps, were cited as an additional uncertainty. While only about 1% of Alignment’s risk‑coding value comes from chart reviews, and an even smaller slice from the unlinked type potentially at risk, broader policy shifts could still reshape reimbursement dynamics for the sector.

Competitive and Distribution Shifts

Industry disruption, including some rivals pulling back, is creating openings for Alignment but also signaling volatility in Medicare Advantage. The company is recalibrating its distribution and broker strategies and is still finalizing provider arrangements in at least one planned new‑state entry, which may slow or limit near‑term expansion in that market.

Seasonality, Part D Trends and Utilization Pressure

Management expects MBR to be modestly lower in the first half of 2026 than the full‑year average because of normal Part C seasonality and a flatter Part D pattern. They also pointed to ongoing utilization pressure across Medicare Advantage, suggesting that cost discipline and risk adjustment will remain crucial levers to protect margins.

Early but Rapid Expansion Beyond California

Membership outside California more than doubled to about 38,000, now roughly 16% of the total base, across 23 non‑California counties. However, market share outside the home state remains under 4%, leaving significant runway but also highlighting that the growth story is still in relatively early innings geographically.

Forward-Looking Guidance and 2026 Outlook

Initial 2026 guidance calls for year‑end membership between 292,000 and 298,000 and revenue of $5.14–5.19 billion, implying about 31% growth at the midpoint. Management projects adjusted gross profit of $615–650 million and adjusted EBITDA of $133–163 million, with a modestly lower MBR in the first half than the full year and ongoing SG&A leverage despite regulatory and mix headwinds.

Alignment’s earnings call painted the picture of a high‑growth Medicare Advantage player steadily gaining scale, profitability and quality recognition, even as it navigates a tougher policy backdrop. For investors, the key takeaways are accelerating membership, improving margins, robust cash, and measured optimism that technology and disciplined execution can offset regulatory and utilization pressures ahead.